Starboard Value Takes Aim at Dynatrace: Activist Push for Big Stock Boost
Starboard Value pushes Dynatrace to cut costs and boost buybacks to lift its struggling stock despite strong AI potential.
NOTRELOAD AI
OpenAI Misses Sales and User Targets, Drags Partner Stocks Down
OpenAI missed growth targets, worrying investors as rivals rise and AI costs stay high, raising doubts about quick profits. Shares of SoftBank, Oracle, and AMD dropped sharply.
Bed Bath & Beyond Beats Q1 Estimates with First Revenue Growth in 19 Quarters
Bed Bath & Beyond beat forecasts, cut costs, improved sales, and is shifting from survival to growth with a leaner business model.
Catalyst Pharmaceuticals Stock Surges on Angelini Pharma Buyout Rumors
Angelini Pharma may buy Catalyst Pharmaceuticals. Talks are early, but news pushed Catalyst’s stock up. No deal is certain yet.
Starboard Value Takes Big Stake in Flowserve and Pushes for Higher Profits
Starboard buys big stake in Flowserve, pushes for higher profits as AI boosts power demand; stock rises on growth hopes.
Craig-Hallum Initiates Strong Buy on Spruce Biosciences with $140 Price Target as TA-ERT Advances Toward Approval
Spruce Biosciences has a rare disease drug (TA-ERT) showing strong results, FDA path clear, big sales and upside potential.